SB 2096 Hawaii Senate · 2026 Regular Session

RELATING TO WASTEWATER MANAGEMENT.

Summary

Requires certain wastewater treatment works to test sewage sludge and any other residual material intended for land application for the presence of PFAS. Requires the Director of Health to adopt rules for the monitoring, sampling, testing, and data collection of sewage sludge and other residual material at wastewater treatment works that contain PFAS. Effective 7/1/3000. (HD1)

Issues: ✓ Environment

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2026

Committee Review

Mar 2026

Senate Passage

Mar 2026

House Passage

Governor

Introduced Jan 14, 2026 Last action Mar 19, 2026

Maddy AI version diff · 3 comparisons

What changed between versions

SB2096_SD1 → SB2096_SD2 · 3 edits

MINOR

This bill version updates the legislative metadata to reflect a second draft (SD2) instead of the first (SD1), changing the author's name and several internal tracking numbers. The core policy text regarding PFAS testing in wastewater sludge remains substantively identical, with only minor formatting adjustments to the text layout.

Scope change

The scope of the bill's policy requirements has not changed; only the administrative metadata and formatting have been updated.

TECHNICAL

The bill version identifier was changed from SD1 to SD2, and the author's name was updated from Fredrick Akau to Joseph Brown.

Internal tracking numbers, including bill numbers, revision counts, and timestamps, were updated to reflect the new draft version.

Minor formatting adjustments were made to the text of Section 1 and Section 5, specifically regarding the spacing and alignment of the PFAS testing requirement and the formatting of the statutory repealer clause.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 19, 2026

Committee

Reported from EEP (Stand. Com. Rep. No. 1220-26) as amended in HD 1, recommending passage on Second Reading and referral to WAL.

lower

Mar 17, 2026

Lower · Passed

The committee on EEP recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Lowen, Perruso, Chun, Kahaloa, Kusch, Quinlan, Matsumoto; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none.

lower

Mar 12, 2026

Committee

Referred to EEP, WAL, JHA, referral sheet 17

lower

Mar 10, 2026

Introduced

Received from Senate (Sen. Com. No. 167) in amended form (SD 2).

lower

Mar 10, 2026

Upper · Passed

Report adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

upper

Mar 3, 2026

Upper · Passed

The committee(s) on WAM recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in WAM were as follows: 12 Aye(s): Senator(s) Dela Cruz, Moriwaki, DeCoite, Elefante, Hashimoto, Inouye, Kanuha, Kidani, Kim, Lee, C., Richards, Wakai; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.

upper

Feb 27, 2026

Upper · Passed

The committee(s) on WAM will hold a public decision making on 03-03-26 10:17AM; Conference Room 211 & Videoconference.

upper

Feb 13, 2026

Upper · Passed

Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.

upper

Feb 13, 2026

Committee

Reported from HHS/AEN (Stand. Com. Rep. No. 2251) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.

upper

Feb 2, 2026

Upper · Passed

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 3 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Keohokalole, Fevella.

upper

Jan 30, 2026

Upper · Passed

The committee(s) on HHS/AEN has scheduled a public hearing on 02-02-26 3:00PM; CR 224 & Videoconference.

upper

Jan 28, 2026

Upper · Passed

The committee(s) on AEN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in AEN were as follows: 5 Aye(s): Senator(s) Gabbard, Richards, DeCoite, Rhoads, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

upper

Jan 22, 2026

Committee

Referred to HHS/AEN, WAM.

upper

Jan 21, 2026

Introduced

Introduced and passed First Reading.

upper

Jan 14, 2026

Introduced

Pending Introduction.

upper

3 primary · 2 co-sponsors